Candriam SCA’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Candriam SCA's ALAB Position: Q2 2026 in Review
Candriam SCA increased its Astera Labs (ALAB) stake by 21% in Q2 2026, buying an estimated $1.98M and bringing the position to 43,200 shares worth $20.8M. The position accounts for 0.09% of the portfolio, ranked #197.
Candriam SCA first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Candriam SCA held 43,200 shares of Astera Labs worth $20.8M as of Q2 2026.
- Candriam SCA bought 7,458 Astera Labs shares in Q2 2026, an estimated $1.98M.
- Astera Labs made up 0.09% of Candriam SCA's portfolio in Q2 2026, its #197 holding.
- Candriam SCA first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.